These outcomes, along with a prior report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the principle of focusing on ACKR3 as a singular way to modulate the opioid procedure, which could open new therapeutic avenues for opioid-linked Issues. A research research released in https://romainm626sru3.blogdal.com/profile